Semler Scientific acquired 185 Bitcoin between Might twenty third and June third for about $20 million, at a median worth of $107,974 per coin.
The acquisition was funded by means of proceeds from the corporate’s at-the-market (ATM) fairness providing program.
“We proceed to accretively develop our Bitcoin arsenal utilizing working money movement and proceeds from debt and fairness financings,” stated Chairman Eric Semler.
“And we’re excited to launch the Semler Scientific dashboard immediately on our web site to supply the general public with usually up to date data on our Bitcoin holdings and different key metrics.”
Since launching the ATM program in April 2025, the corporate has raised roughly $136.2 million by means of the sale of over 3.6 million frequent shares.
As of June third, Semler holds 4,449 Bitcoin, acquired at a complete value of $410 million, with a median buy worth of $92,158. The holdings are at present valued at about $446.2 million.
On X, Semler wrote: “SMLR acquires 185 Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC.”
$SMLR acquires 185 #Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC. 🚀
— Eric Semler (@SemlerEric) June 4, 2025
Semler makes use of BTC Yield as a key efficiency indicator (KPI) to judge its Bitcoin technique.
In keeping with the corporate’s Type 8-Okay, the metric is meant to “complement an investor’s understanding” of its determination to fund Bitcoin purchases by means of fairness or convertible devices.
Yr-to-date, the BTC Yield stands at 26.7%.
In Q1 2025, Semler reported an working lack of $31.1 million, in comparison with a $7.0 million revenue in the identical interval final 12 months.
Income declined 44% year-over-year to $8.8 million, whereas working bills rose to $39.9 million, largely resulting from a $29.8 million contingent legal responsibility tied to a possible Division of Justice settlement.
Commenting on the corporate’s operations, CEO Doug Murphy-Chutorian stated, “our healthcare enterprise is seeing inexperienced shoots from the cardiovascular product line that we launched to our massive enterprise buyer base this 12 months. We predict progress and money technology from these FDA-cleared services, which is able to add to our bitcoin treasury technique.”
Share this text